Spanish Study: Update February 2000
A pilot study of MDMA therapy in the treatment of PTSD has been approved and will be the first formal therapy study with MDMA ever conducted. (Read current update) MAPS has pledged $54,000 for this study; …
Pharmacological Effects of MDMA in Humans
Investigator: Jordi Cam, MD, Magi Farr, MD, et al. Institut Municipal d’Investigacio Medica – Barcelona, Spain Contact: Jordi Camí, MD or Magi Farré, MD Sponsor: Funded in part by …
Psychobiologic Effects of MDMA in Humans
Investigators: Charles S. Grob, MD, and Russell E. Poland, PhD Harbor-UCLA Medical Center – Torrance, California, USA Sponsor: MAPS, Harbor/UCLA Contact: , FDA-approved Phase 1 dose-response safety …
Guided, Structured, Group Use of Entheogenic Substances in Western Culture
(doctoral dissertation) Investigator: Roger Marsden California Institute of Integral Studies, Clinical Psychology Contact: Sponsors: 1998 Kranzke Scholarship; MAPS What are the different frameworks being …
Low-dose MDMA
Investigator: John Henry, MD University College London, England Contact: This was a neurotoxicity study. Henry is directing additional MDMA studies at this time. Fallon JK, Kicman AT, Henry JA, Milligan …
Psycholytic Therapy with MDMA and LSD in Switzerland
Investigators: Marianne Bloch, MD, Jurai Styk, MD and Dr. Samuel Widmer, MD Sponsor: Swiss Medical Society for Psycholytic Therapy From 1988 to 1993 therapists with the Swiss Medical Society for Psycholytic …
Acute Effects of 3, 4 – Methylenedioxymethamphetamine(MDMA)
Investigators: Alex Gamma, PhD, Franz Vollenweider, MD Psychiatric University Hospital – Zrich, Switzerland Sponsor: UBS Science Foundation and others Contact: Franz Vollenweider, MD, Alex Gamma …
The Concord Prison Experiment Experiment Follow-Up
Investigator: Rick Doblin, Ph.D. This study, originally published in the Journal of Psychoactive Drugs [Oct-Dec 1998] is one in a series of long-term follow-ups to early psychedelic research that MAPS …
Psychedelic Effects of Ketamine in Healthy Volunteers
Investigators: Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ, Roy- Byrne PP Department of Psychiatry, Harborview Medical Center, University of Washington, Seattle Ketamine or saline was administered …
MAPS Conference on the Clinical Utility of MDMA and MDE
August 30 - September 1, 1999. MAPS Conference on the Clinical Utility of MDMA and MDE (Dead Sea Conference). George Greer, MD. 56K: Clip 1 / Clip 2 28K: Clip 1 / Clip 2 Charles Grob, MD. 56K: Clip 1 / …
Researchers Present MDMA Research Results at Israeli MAPS MDMA Symposium
On September 1, 1999, Jordi Camí, MD, PhD, Magi Farré, MD, PhD, and José Carlos Bouso, PhD presented their Phase 1 clinical study of MDMA-assisted psychotherapy for PTSD at the MAPS MDMA …
Autumn 1999 – MAPS Israel MDMA Conference
MAPS organized an international symposium on the medical utility of MDMA. Talks from this event, held August 31 to September 1, 1999, are posted on this site (talks by George Greer, Juraj and Sonja Styk …
